Evidence map›Paper›PMID 38077358›Full record

ReviewFrontiers in immunology2023

Houttuynia cordata thunb. alleviates inflammatory bowel disease by modulating intestinal microenvironment: a research review.

Si Wang, Lei Li, Yuhan Chen, Qian Liu, Shengyu Zhou, Ning Li, Yueying Wu, Jiali Yuan

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Mechanisms of action and applications ofFrontiers in pharmacology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Si Wang *First Clinical School of Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Lei Li *College of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Yuhan ChenCollege of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Qian LiuCollege of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Shengyu ZhouCollege of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Ning LiFirst Clinical School of Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Yueying WuCollege of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Jiali YuanCollege of Basic Medical Sciences, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Yunnan University · CNYunnan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a complex group of chronic intestinal diseases, the cause of which has not yet been clarified, but it is widely believed that the disorder of the intestinal microenvironment and its related functional changes are key factors in the development of the disease. Houttuynia cordata thunb. is a traditional plant with abundant resources and long history of utilization in China, which has attracted widespread attention in recent years due to its potential in the treatment of IBD. However, its development and utilization are limited owing to the aristolochic acid alkaloids contained in it. Therefore, based on the relationship between the intestinal microenvironment and IBD, this article summarizes the potential mechanisms by which the main active ingredients of Houttuynia cordata thunb., such as volatile oils, polysaccharides, and flavonoids, and related traditional Chinese medicine preparations, such as Xiezhuo Jiedu Formula, alleviate IBD by regulating the intestinal microenvironment. At the same time, combined with current reports, the medicinal and edible safety of Houttuynia cordata thunb. is explained for providing ideas for further research and development of Houttuynia chordate thunb. in IBD disease, more treatment options for IBD patients, and more insights into the therapeutic potential of plants with homology of medicine and food in intestinal diseases, and even more diseases.

Indexed as

AlkaloidsDrugs, Chinese HerbalHouttuyniaInflammatory Bowel DiseasesHumansPlant ExtractsAlkaloidsDrugs, Chinese HerbalPlant Extractshomology of medicine and foodHouttuynia cordata thunb.immunityinflammatory bowel diseaseintestinal microenvironment

Identifiers

PMID38077358
PMCPMC10702737
OpenAlexW4388940846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.